Prognostic Factors for Operated Gallbladder Cancer

  • Bala Basak Oven Ustaalioglu
  • Ahmet Bilici
  • Mesut Seker
  • Umut Kefeli
  • Dincer Aydin
  • Serkan Celik
  • Tarik Demir
  • Burcak Erkol
Original Research



The prognosis of gallbladder cancer is poor. Lymph node metastasis and the stage are known to be the strongest prognostic factors for survival. The aim of this study was to determine the importance of complementary surgery and other prognostic factors for survival of operated gallbladder cancer.

Material and Method

We retrospectively analyzed 62 localized gallbladder cancers. The prognostic factors for survival were evaluated by univariate and multivariate analysis.


The 3-year overall survival (OS) and disease-free survival (DFS) rates were 52.8 and 43.5%, respectively. Totally, 37 patients (59.6%) were diagnosed incidentally during simple cholecystectomy which was performed for benign causes but only 56.4% of them underwent complementary surgery. 51.6% of the recurrence was detected during 18.4 months of follow-up time. R0 resection, T stage, and pathological stage were found to be related with both OS and DFS by univariate analysis. Grade, lymph node metastasis, and adjuvant chemotherapy were also related with DFS. Presence of recurrence, recurrence side, performance score (PS), and perineural invasion (PNI) were related with OS. Peritoneal metastasis, advanced stage disease, and lymph node metastasis were more common among patients who did not undergo complementary surgery. Adjuvant chemotherapy was given more frequently to patients who undergone complementary surgery group. The multivariate analysis indicated that grade, lymph node metastasis, stage, recurrence site, PS, and adjuvant chemotherapy stage were independent prognostic factors for DFS on the other and only stage was a prognostic factor for OS.


Our results showed that incidental diagnosis or complementary surgery was not related with DFS or OS but stage was only an independent prognostic factor for both OS and DFS in resected gallbladder cancer.


Gallbladder Cancer Operation Prognostic factors 


Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.


  1. 1.
    Nigri G, Berardi G, Mattana C, Mangogna L, Petrucciani N, Sagnotta A, et al. Routine extra-hepatic bile duct resection in gallbladder cancer patients without bile duct infiltration: a systematic review. Surgeon. 2016;14:337–44.CrossRefPubMedGoogle Scholar
  2. 2.
    Ebata T, Ercolani G, Alvaro D, Ribero D, Di Tommaso L, Valle JW. Current status on cholangiocarcinoma and gallbladder cancer. Liver Cancer. 2016;6:59–65.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Goetze TO. Gallbladder carcinoma: prognostic factors and therapeutic options. World J Gastroenterol. 2015;21:12211–7.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Dorobisz T, Dorobisz K, Chabowski M, Pawłowski W, Janczak D, Patrzałek D, et al. Incidental gallbladder cancer after cholecystectomy: 1990 to 2014. Onco Targets Ther. 2016;9:4913–6.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Chen C, Geng Z, Shen H, Song H, Zhao Y, Zhang G, et al. Long-term outcomes and prognostic factors in advanced gallbladder cancer: focus on the advanced T stage. PLoS One. 2016;11:e0166361.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Wilkinson DS. Carcinoma of the gall-bladder: an experience and review of the literature. Aust N Z J Surg. 1995;65:724–7.CrossRefPubMedGoogle Scholar
  7. 7.
    Lim H, Seo DW, Park DH, Lee SS, Lee SK, Kim MH, et al. Prognostic factors in patients with gallbladder cancer after surgical resection: analysis of 279 operated patients. J Clin Gastroenterol. 2013;47:443–8.CrossRefPubMedGoogle Scholar
  8. 8.
    Sheinfeld W. Cholecystectomy and partial hepatectomy for carcinoma of the gall bladder with local liver extension. Surgery. 1947;22:48–58.PubMedGoogle Scholar
  9. 9.
    NCCN. Clinical Practice Guidelines in Oncology, Hepatobiliary cancer, version 2,2017, May 25,2017.Google Scholar
  10. 10.
    Clemente G. Unexpected gallbladder cancer: surgical strategies and prognostic factors. World J Gastrointest Surg. 2016;8:541–4.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Go SI, Kim YS, Hwang IG, Kim EY, Oh SY, Ji JH, et al. Is there a role for adjuvant therapy in R0 resected gallbladder cancer?: a propensity score-matched analysis. Cancer Res Treat. 2016;48:1274–85.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Kanthan R, Senger JL, Ahmed S, Kanthan SC. Gallbladder cancer in the 21st century. J Oncol. 2015;2015:967472.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Takada T, Amano H, Yasuda H, Nimura Y, Matsushiro T, Kato H, et al. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer. 2002;95:1685–95.CrossRefPubMedGoogle Scholar
  14. 14.
    Aloia TA, Jarufe N, Javle M, Maithel SK, Roa JC, Adsay V, et al. Gallbladder cancer: expert consensus statement. HPB (Oxford). 2015;17:681–90.CrossRefPubMedCentralGoogle Scholar
  15. 15.
    Butte JM, Matsuo K, Gönen M, D'Angelica MI, Waugh E, Allen PJ, et al. Gallbladder cancer: differences in presentation, surgical treatment, and survival in patients treated at centers in three countries. J Am Coll Surg. 2011;212:50–61.CrossRefPubMedGoogle Scholar
  16. 16.
    Choi SB, Han HJ, Kim CY, Kim WB, Song TJ, Suh SO, et al. Incidental gallbladder cancer diagnosed following laparoscopic cholecystectomy. World J Surg. 2009;33:2657–63.CrossRefPubMedGoogle Scholar
  17. 17.
    Zhang WJ, Xu GF, Zou XP, Wang WB, Yu JC, Wu GZ, et al. Incidental gallbladder carcinoma diagnosed during or after laparoscopic cholecystectomy. World J Surg. 2009;33:2651–6.CrossRefPubMedGoogle Scholar
  18. 18.
    Wullstein C, Woeste G, Barkhausen S, Gross E, Hopt UT. Do complications related to laparoscopic cholecystectomy influence the prognosis of gallbladder cancer? Surg Endosc. 2002;16:828–32.CrossRefPubMedGoogle Scholar
  19. 19.
    Margonis GA, Gani F, Buettner S, Amini N, Sasaki K, Andreatos N, et al. Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium. HPB (Oxford). 2016;18:872–8.CrossRefGoogle Scholar
  20. 20.
    Ahn Y, Park CS, Hwang S, Jang HJ, Choi KM, Lee SG. Incidental gallbladder cancer after routine cholecystectomy: when should we suspect it preoperatively and what are predictors of patient survival? Ann Surg Treat Res. 2016;90:131–8.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Hensen D, Albores-Saaverda J, Corle D, et al. Carcinoma of the gallbladder. Histologic types, stage of disease, grade, and survival rates. Cancer. 1992;70:1493–7.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Bala Basak Oven Ustaalioglu
    • 1
  • Ahmet Bilici
    • 2
  • Mesut Seker
    • 3
  • Umut Kefeli
    • 4
  • Dincer Aydin
    • 5
  • Serkan Celik
    • 1
  • Tarik Demir
    • 3
  • Burcak Erkol
    • 1
  1. 1.Medical OncologyHaydarpasa Numune Education and Research HospitalIstanbulTurkey
  2. 2.Medical OncologyMedipol UniversityIstanbulTurkey
  3. 3.Medical OncologyBezm-i Alem Vakıf Gureba UniversityIstanbulTurkey
  4. 4.Medical OncologyKocaeli UniversityIstanbulTurkey
  5. 5.Medical OncologyKartal Education and Research HospitalIstanbulTurkey

Personalised recommendations